Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 15, 2023
Catalent has completed an expansion project for its clinical supply facility in Singapore at a cost of $2.2 million.
read more
Wednesday, February 15, 2023
Global life sciences platform, Gamma Biosciences, which was created by KKR to serve the advanced therapy market with bioprocessing solutions, has agreed to a deal with Biotage AB, a Swedish life sciences company.
read more
Tuesday, February 14, 2023
Biodextris Inc., a subsidiary of Clean Biologics SAS, announced the development of a new industrial-scale vaccine and biologics development, manufacturing and packaging plant (CDMO).
read more
Monday, February 13, 2023
Labcorp announced that the new company to be formed by the planned spin-off of its Clinical Development business will be known as Fortrea.
read more
Monday, February 13, 2023
Quotient Sciences announced that it has completed an expansion of its early-phase formulation development capabilities for oral dosage forms at its Nottingham, UK, facility.
read more
Tuesday, February 07, 2023
Syneos Health® a fully integrated biopharmaceutical solutions organization, announced a strategic partnership with Haystack Health, a Roivant Health portfolio company developing advanced Artificial Intelligence (AI) and Natural Language Processing (...
read more
Tuesday, February 07, 2023
Flagship Biosciences, a provider of spatial biology and biomarker analytics services, announced a strategic partnership with Genomenon® that aims to transform the drug development paradigm with accelerated biomarker discovery and companion ...
read more
Tuesday, February 07, 2023
Upsher-Smith Laboratories, LLC announced the opening of its new, 270,000 square-foot, state-of-the-art greenfield manufacturing facility. The Maple Grove, Minnesota facility offers fully up-to-date packaging and serialization capabilities and ...
read more
Monday, February 06, 2023
Pangaea Data, (Pangaea), provider of a novel AI-driven product for characterizing patients by mapping their journeys and disease trajectories in a privacy-preserving and scalable manner, today announced that it has been named “Digital Solution of the...
read more
Monday, February 06, 2023
The Association of Diversity in Clinical Trials (AOD) is being launched and introduced at upcoming industry conferences SCOPE and the Health Equity in Clinical Trials Congress this month. The AOD will become the first entity to represent industry in ...
read more
Friday, February 03, 2023
Accenture has acquired Bionest, a strategy and consulting firm dedicated to addressing complex strategic decisions for leading biopharma organizations across innovative areas of science including precision medicine and diagnostics, oncology, cell & ...
read more
Friday, February 03, 2023
Personalis, Inc., a provider of advanced genomics for precision oncology, and Moderna, Inc. announced the companies have signed a new agreement to continue using the Personalis NeXT Platform® as part of upcoming clinical studies evaluating mRNA-4157/...
read more
Tuesday, January 31, 2023
Seqens Group, an integrated company involved in the development and manufacture of active pharmaceutical ingredients (APIs) and intermediates, has opened Seqens Boston R&D Center, a state-of-the-art, 15,000 square-foot R&D center in Devens, Mass. ...
read more
Tuesday, January 31, 2023
Charles River Laboratories International has acquired SAMDI Tech, Inc, a provider of high-quality, label-free high-throughput screening (HTS) solutions for drug discovery research. The acquisition marks the culmination of a partnership between the ...
read more
Tuesday, January 31, 2023
Mural Health, a clinical trials technology company that improves the patient and caregiver experience in order to improve enrollment rates, participant retention, and increase protocol compliance and Ledger Run, a company focused on optimizing ...
read more